Literature DB >> 1201471

Use of chloroquine in shock.

C E Famewo, W H Noble, M B Garvey.   

Abstract

One group of dogs received single doses of intramuscular chloroquine and another group served as a control. The dogs were subjected to haemorrhagic shock and then retransfused with their own blood after two hours of shock. The chloroquine-treated dogs had normal PA pressures after correction of acidosis and significantly smaller increases in the pulmonary vascular resistance. The results are similar but less marked than those obtained with aspirin. Chloroquine inhibited in vitro platelet aggregation by 50% and was not associated with any increased bleeding. This may be an advantage when used in patients with multiple trauma or increased bleeding tendency.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201471     DOI: 10.1007/bf03013317

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  5 in total

1.  Use of antimalarial drugs as "desludging" agents in vascular disease processes.

Authors:  B P MADOW
Journal:  J Am Med Assoc       Date:  1960-04-09

2.  Thermal and conductivity dilution curves for rapid quantitation of pulmonary edema.

Authors:  W H Noble; J W Severinghaus
Journal:  J Appl Physiol       Date:  1972-06       Impact factor: 3.531

3.  Computer analysis of respiratory data.

Authors:  D Duncalf; S Kuwabara
Journal:  Anesth Analg       Date:  1971 Sep-Oct       Impact factor: 5.108

4.  Use of aspirin in haemorrhagic shock.

Authors:  C E Famewo; W H Noble; M B Garvey
Journal:  Can Anaesth Soc J       Date:  1975-01

5.  Prevention of postoperative deep venous thrombosis and pulmonary embolism.

Authors:  A E Carter; R Eban; R D Perrett
Journal:  Br Med J       Date:  1971-02-06
  5 in total
  1 in total

1.  Pulmonary vascular effects of acetylsalicylic acid, chloroquine, dextran and methylprednisolone given after haemorrhagic shock in dogs.

Authors:  W H Noble; C E Famewo; M B Garvey
Journal:  Can Anaesth Soc J       Date:  1977-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.